Rigel Pharma (RIGL) Tops Q4 EPS by 80c
Rigel Pharma (NASDAQ: RIGL) reported Q4 EPS of $0.80. Revenue for the quarter came in at $57.6 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Rigel Pharma (NASDAQ: RIGL) reported Q4 EPS of $0.80. Revenue for the quarter came in at $57.6 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.